115 related articles for article (PubMed ID: 10402239)
1. E-cadherin and beta-catenin expression in breast medullary carcinomas.
Charpin C; Bonnier P; Garcia S; Andrac L; Crebassa B; Dorel M; Lavaut MN; Allasia C
Int J Oncol; 1999 Aug; 15(2):285-92. PubMed ID: 10402239
[TBL] [Abstract][Full Text] [Related]
2. P-cadherin expression in breast carcinoma indicates poor survival.
Peralta Soler A; Knudsen KA; Salazar H; Han AC; Keshgegian AA
Cancer; 1999 Oct; 86(7):1263-72. PubMed ID: 10506713
[TBL] [Abstract][Full Text] [Related]
3. Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: an immunohistochemical study with keratin 19 and oestrogen receptor staining.
Jensen ML; Kiaer H; Melsen F
Histopathology; 1996 Sep; 29(3):241-5. PubMed ID: 8884352
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin catenin and C-erbB-2 gene products in invasive ductal-type breast carcinomas.
Nagae Y; Kameyama K; Yokoyama M; Naito Z; Yamada N; Maeda S; Asano G; Sugisaki Y; Tanaka S
J Nippon Med Sch; 2002 Apr; 69(2):165-71. PubMed ID: 12068329
[TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin and catenins in invasive mammary carcinomas.
Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
[TBL] [Abstract][Full Text] [Related]
7. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments].
Bukholm IK; Nesland JM; Børresen-Dale AL
J Pathol; 2000 Jan; 190(1):15-9. PubMed ID: 10640987
[TBL] [Abstract][Full Text] [Related]
8. c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma.
Nakopoulou L; Gakiopoulou H; Keramopoulos A; Giannopoulou I; Athanassiadou P; Mavrommatis J; Davaris PS
Histopathology; 2000 Apr; 36(4):313-25. PubMed ID: 10759945
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of beta-catenin in in situ and invasive breast cancer.
Karayiannakis AJ; Nakopoulou L; Gakiopoulou H; Keramopoulos A; Davaris PS; Pignatelli M
Eur J Surg Oncol; 2001 Feb; 27(1):31-6. PubMed ID: 11237489
[TBL] [Abstract][Full Text] [Related]
10. Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas.
Kovács A; Dhillon J; Walker RA
Mol Pathol; 2003 Dec; 56(6):318-22. PubMed ID: 14645693
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas.
Blanco MJ; Moreno-Bueno G; Sarrio D; Locascio A; Cano A; Palacios J; Nieto MA
Oncogene; 2002 May; 21(20):3241-6. PubMed ID: 12082640
[TBL] [Abstract][Full Text] [Related]
12. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.
Wong SC; Lo SF; Lee KC; Yam JW; Chan JK; Wendy Hsiao WL
J Pathol; 2002 Feb; 196(2):145-53. PubMed ID: 11793365
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
14. The expression of E-cadherin-catenin complex in adenoid cystic carcinoma of salivary glands.
Zhang ZY; Wu YQ; Zhang WG; Tian Z; Cao J
Chin J Dent Res; 2000 Nov; 3(3):36-9. PubMed ID: 11314533
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44.
Bànkfalvi A; Terpe HJ; Breukelmann D; Bier B; Rempe D; Pschadka G; Krech R; Lellè RJ; Boecker W
Histopathology; 1999 Jan; 34(1):25-34. PubMed ID: 9934581
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study of P-cadherin in breast cancer].
Kovács A; Walker RA; Nagy A; Gomba S; Jones L; Dearing S
Orv Hetil; 2002 Feb; 143(8):405-9. PubMed ID: 11921707
[TBL] [Abstract][Full Text] [Related]
17. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
18. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry.
Kajiwara M; Toyoshima S; Yao T; Tanaka M; Tsuneyoshi M
J Surg Oncol; 1999 Apr; 70(4):209-16. PubMed ID: 10219015
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between the expression of E-cadherin-catenins and alpha-, beta-, gamma-catenin and the metastasis and prognosis of breast cancer].
Zou W; Hu CH; Zhou JP
Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):499-502. PubMed ID: 12658921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]